BidRoverOPPORTUNITY INTELLIGENCE
Sign inGet free alerts

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

National Institutes of Health · Due Dec 23, 2027

Buyer
National Institutes of Health
Deadline
Due Dec 23, 2027
Posted
Nov 22, 2024
Location
United States
Category
Healthcare
Type
Grant opportunity
Notice ID
RFA-HL-26-017
Source
Grants.gov

Description

National Institutes of Health published this posted funding opportunity on Grants.gov.

View official notice ↗

What BidRover found in this bid

  • Requirements extractedpending review
  • Source documents readlisting only
  • Fit score for your businessworkspace only
  • Bid / no-bid briefworkspace only

Create a free account to save this search and get weekly alerts. Requirements, document reading, fit scores and team review are part of the paid workspace.

Similar open bids

  1. Grants.gov · Forecasted grant opportunityHIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)National Institutes of HealthUnited StatesHealthcareNo deadline supplied · Posted Oct 1, 2026
  2. Grants.gov · Forecasted grant opportunityEarly to Definitive Clinical Trials (R61/R33 Clinical Trial Required)National Institutes of HealthUnited StatesResearch & scientific servicesNo deadline supplied · Posted Sep 29, 2026
  3. Grants.gov · Forecasted grant opportunityResearch to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesNational Institutes of HealthUnited StatesResearch & scientific servicesNo deadline supplied · Posted Sep 22, 2026
  4. Grants.gov · Forecasted grant opportunityAmyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)National Institutes of HealthUnited StatesResearch & scientific servicesNo deadline supplied · Posted Sep 23, 2026
  5. Grants.gov · Forecasted grant opportunitySomatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)National Institutes of HealthUnited StatesResearch & scientific servicesNo deadline supplied · Posted Sep 14, 2026
  6. Grants.gov · Forecasted grant opportunitySomatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)National Institutes of HealthUnited StatesResearch & scientific servicesNo deadline supplied · Posted Sep 14, 2026

BidRover copies listing details from Grants.gov. Always confirm requirements, amendments and submission instructions in the official notice before responding.